Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
*PFIZER TO BUY ARENA PHARMACEUTICALS FOR $100/SHR IN CASH
92% premium
Upper lip?
Wait - you mean they did not wait to announce this at a conference ….. EYE ROLL
Yes - but so what. Generics will continue to eat at the table. So Hikma goes away Reddy is not going anywhere
Serious Question - does it really matter? Pharmacist is still going to swap out prescriptions for the generic version no matter what. It’s the true reality.
What will really change?
At least they revamped the slides - I like these much better.
Yup - tie up loose ends as you focus in on main prize.
Close to GAME OVER - we are fighting a war that can not be won. Everyone…EVERYONE is against us……you can’t win a war with those odds….the end is near
I’ve always thought the PFE acquisition of Amarin is on hold until this Rule 60 process runs out.
The Canada deal is training as they wait for the legal action to play out.
Vascepa prescription with every vaccine
I will drink to that
Expectation is too high - we all know this will most likely crash on Monday
People shorting this knowing the results will most likely be mediocre and a Monday fall is most likely.
I hope I’m wrong…..but this is Amarin
Anticipated completion now a day after ESC presentation? I’m confused
Working on emergency use authorization?
Makes ZERO sense to hold back any amazing results and embargo the data if we could be saving lives now.
I’m afraid we are all being set up to be disappointed with less than amazing results.
I sure hope I’m wrong - but the embargo makes no sense to me is the middle of this serious pandemic.
Yes indeed
How do they prevent raising more cash at this point. FDA approval so far away after having to run “healthy volunteer pharmacokinetic study” - trying to submit by end of year. They do not have enough cash to make it through FDA decision - 2nd quarter 2022 at the earliest.
From PR
As of June 30, 2021, cash and cash equivalents were $22.1 million, compared with $35.3 million as of December 31, 2020.
No mention of PREPARE-IT….no mention of treating COVID
This does not bode well for trials? Not sure if we need to read into this or not?
You can feel the new tone of the earnings PR
GOOD STUFF
Holy Cow - what a vote of confidence for Karim. Those are all large buys.
Only fitting that stock is down on CEO’s last day…..and the chapter is now closed
That’s how the big boys do it
Here are a few of mine in priority order
4
7
5
8
12
16
A bourbon of course
Playbook - my prediction
Karim and team are already discussing with many government agencies (multiple countries) on COVID trial results (they were able to get exemption from embargo rule in place)
Upon results being shared at conference we will get:
1 - incredible results
2 - PR stating purchase of X by certain countries under the emergency use rules
3 - stock shoots to 12
4 - I drink a ton in celebration
Eom
JUST AMAZING
If it breaks 4…..look out below
What a great looking - 5 day chart AND 1 month chart and especially the 6 month chart.
Really solid
The SILENCE coming from the company is deafening …. something seems odd
I think we are seeing institutional dumping this week….they still own over 20% of float….I think they have been unloading
They are playing this masterfully
Short it down 5%…..ensure level is maintained
Rinse and repeat
Hope the trend changes soon
Amazing how PreMarket volume has essentially went away……float is nearly held and controlled now by retail….crazy
We need to close at a big number to start the margin call dominoes to fall…
What is that number? $72, $80 ?!
100% agree
BULLISH
Solid gain on weak volume = bullish
Yea - that’s good…..very true
Where is the volume? We need volume
100% Agree